Navigation Links
Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms
Date:5/15/2008

hat there is no more than a 5 in 100 chance that the difference observed between the groups could have been obtained by chance.


'/>"/>

Contact: Molly Rabinovitz
mrabinovitz@wcpglobal.com
312-933-7873
American Gastroenterological Association
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. ReBuilder Medical Technologies, Inc. Reports Monthly Sales in 2007 Nearly Doubling Monthly Sales in 2006, Including Record Daily Sales in September 2007
2. Nearly 30 Percent of Realtors(R) Lack Health Insurance
3. New Poll Finds Nearly Seven in 10 New Jersey Voters Support Smoke-Free Casinos
4. New Pharmaceutical Sales Force Communication Metrics: Nearly 6 Weeks of Sales Time per Rep Wasted Each Year
5. Anticancer Drugs Targeting the ErbB (EGFr/HEr2) Pathway Alone Generated Global Sales of Nearly $5 Billion in the First Nine Months of 2007
6. K-State Researchers Predict That an Outbreak of Foot-And-Mouth Disease Could Cost Kansas Nearly a Billion Dollars
7. Smokers Cost Medicaid System Nearly $10 Billion
8. Research Indicates Nearly 25 Percent of Supplements Are Contaminated With Steroids, Stimulants and Banned Substances
9. Cipla Offers Modest AIDS Drug Price Cut: Not Nearly Enough, says AHF
10. Metabolic syndrome affects nearly 1 in 10 US teens
11. Eleven Florida Nonprofit Organizations to Receive Grants Totaling Nearly $1 Million From The Blue Foundation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... chains are often blamed for the increasing rates ....au however finds that 80% of people think that pa... (PRWEB) November 9, 2009 -- If ... behind Australia’s obesity epidemic, think ...standers. A recent survey commissioned for Fitnes...
(Date:11/9/2009)...o be Offered in April 2010, Provides First Respond... Cambridge, MA (Vocus) November 9, 2009 -- Whe...HR) first inspected a suspected mass grave at Das...eed a team of experts to help interpret the scene....key first step in securing evidence of a human rig...
(Date:11/9/2009)...ncer Network (NCCN) has posted a draft white paper...for near-term comparative effectiveness clinical e...introduces the NCCN Comparative Therapeutic Index(... the risk-versus-benefit of different treatment op...idelines in Oncology(TM). The paper will be posted...
(Date:11/9/2009)...swire/ -- Health Connect Partners, Inc., ( www.hl...ugural Hospital O.R. and Surgery Center Conference...e Hotel in Nashville, Tenn. ,, Health Connect P...ing room directors and managers from some of the l.... Some of the confirmed providers include HCA, Bon...
(Date:11/9/2009)...-- Highlighting a commitment to providing long-ter...ent and digital display technology options, LG Ele...nd Hospital Grade LCD HDTVs this week at the Assoc...nual meeting and exposition (booth #1760). ,, O...ew(TM)" Long-Term Care LCD HDTVs bring a sense of ...
Breaking Medicine News(10 mins):Health News:Fitness.com.au Poll Finds 80% Blame Parents For Our Overweight Kids 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 5
...ransmitter dopamine has long been known to play a ... mutations in a protein called parkin// cause a fo... scientists, reporting in the Jan. 31 issue of The... researchers show for the first time that a mutate...
...ly aggressive treatment with disease-modifying ant...reventing joint damage and avoiding the// fate of ...idely prescribed and generally safe methotrexate, ...sease, which is marked by chronic inflammation of ...
...ium picolinate published in the current edition of...t chromium picolinate is //effective in improving ...eople with type 2 diabetes. The review, whic...zed efficacy after combining results from all type...
...gainst exposing their unborn baby to a 3D ultrasou...such a move is fraught with risks. This// advice h... growing popularity of three dimensional ultrasoun... in 2005, so that they could monitor their baby’s ...
... simple, safe and cost-effective dipstick for the ...ay its low cost, sensitivity and ease of// use mak...gesh Tripathi and colleagues at the India-based De...rated into a dipstick that shows a brown dot if a ...
...ff for a week of sun, snow, and après-ski. And whi...onsider the dangers of skin// cancer? It is ...e than 69,000 new cases reported every year. The i...ferent nationalities behave while having fun in th...
Other Medicine News:Health News:UCLA Find Yields Further Insight into Causes of Parkinson’s Diseas 2Health News:Rheumatoid Arthritis: Early Aggressive Treatment Needed 2Health News:Chromium Picolinate Effective for Diabetes Care 2Health News:Chromium Picolinate Effective for Diabetes Care 3Health News:The Psychology of Skin Cancer 2
(Date:11/9/2009)... Facet Solutions, Inc. today announced that it has...trolled ACADIA(TM) IDE study for lumbar spinal ste...009," stated President and CEO, Geoff Pardo. "It i...omes that surgeons are seeing, and the ease with w...on people are diagnosed with lumbar spinal stenosi...
(Date:11/9/2009).... 9 Hill-Rom (NYSE: H...tion of a joint venture that will focus on the sal...face replacement systems that are intended to be s...for surfaces that are technologically obsolete or ...al leader in patient support systems and related t...
(Date:11/9/2009)...e/ -- Momentum is building for the early December...ond P-MEC India pharma ingredients, services and t...exhibitors from over 80 countries are expected...ts, being held on 1 - 3 December. ,, In additi...lude two new launches. BioPh India will focus on...
Breaking Medicine Technology:Facet Solutions Enrolls 100th Patient in US Pivotal IDE Study 2Hill-Rom and Encompass Group Form Joint Venture 2Hill-Rom and Encompass Group Form Joint Venture 3Hill-Rom and Encompass Group Form Joint Venture 4Hill-Rom and Encompass Group Form Joint Venture 5Forecast Looks Good for India Pharma Shows 2Forecast Looks Good for India Pharma Shows 3While you were sleeping 47771 1While you were sleeping 47771 2Natura Therapeutics and USF receive NIH grant to study green tea compound for Alzheimers 47769 1Natura Therapeutics and USF receive NIH grant to study green tea compound for Alzheimers 47769 2ESC Congress 2009 3A Worlds biggest cardiology meeting to be held in Barcelona 47767 1ESC Congress 2009 3A Worlds biggest cardiology meeting to be held in Barcelona 47767 2
...R-132 could provide a new therapeutic approach for...er, QUEBEC CITY, April 17, 2007 /PRNewswire-FirstC... biopharmaceutical company,focused on endocrine th...tlining in vivo data for its growth hormone-releas...ncer, at the American,Association for Cancer Resea...
...As previously announced, primary endpoint not met;...study treatment with ERBITUX,-, NEW YORK, April 16...ncorporated and Bristol-Myers Squibb Company today...a randomized,open-label, multi-center Phase III t...tecan to irinotecan alone in patients with,metasta...
Other Medicine Technology:AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 2Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 5Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 6Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 8Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 9
SYNCHRON LX®20 PRO
BN100
Bilitec 2000 Recorder
...y, pathology specimen imaging is now advancing tow...tion, analysis, interpretation and telepathology. ...gous to the change that occurred in radiology, and...departments and imaging clinics through the introd...
Medicine Products: